Extended release formulation of etodolac
US6586005B1 · kind B1 · utility
1Cited by
8References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 25, 2000 |
| Grant date | Jul 1, 2003 |
| Priority date | — |
| Expiry date | Aug 25, 2020 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/2054
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A sustained release formulation of etodolac for once daily administration is described.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.